| Source Date | Board Meeting Date | Details |
|
21-Apr-2025
|
06-May-2025
|
Audited Results & Final Dividend
|
|
22-Jan-2025
|
03-Feb-2025
|
Quarterly Results
|
|
18-Oct-2024
|
07-Nov-2024
|
Quarterly Results
|
|
25-Jul-2024
|
08-Aug-2024
|
Quarterly Results
|
|
18-Apr-2024
|
09-May-2024
|
Audited Results & Final Dividend
|
|
18-Jan-2024
|
05-Feb-2024
|
Quarterly Results
|
|
16-Oct-2023
|
07-Nov-2023
|
Quarterly Results
|
|
21-Jul-2023
|
04-Aug-2023
|
Quarterly Results
|
|
24-Apr-2023
|
05-May-2023
|
Final Dividend & Audited Results
|
|
17-Jan-2023
|
01-Feb-2023
|
Quarterly Results
|
|
31-Oct-2022
|
11-Nov-2022
|
Quarterly Results
|
|
20-Jul-2022
|
04-Aug-2022
|
Quarterly Results & Interim Dividend
|
|
20-Apr-2022
|
02-May-2022
|
Audited Results & Dividend
|
|
28-Jan-2022
|
10-Feb-2022
|
Quarterly Results
|
|
29-Oct-2021
|
10-Nov-2021
|
Quarterly Results
|
|
15-Jul-2021
|
26-Jul-2021
|
Quarterly Results
|
|
20-Apr-2021
|
04-May-2021
|
Dividend & Audited Results
|
|
07-Jan-2021
|
19-Jan-2021
|
Quarterly Results
|
|
09-Oct-2020
|
22-Oct-2020
|
Quarterly Results
|
|
03-Aug-2020
|
06-Aug-2020
|
ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2020 ,inter alia, to consider and approve In terms of Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the ?SEBI LODR Regulations?), we wish to inform you that a meeting of the Fund Raising Committee of the board of the directors of the Company is scheduled to be held on 6th August, 2020 inter alia to consider and approve the issue price, including a discount, if any, thereto as permitted under the SEBI ICDR Regulations, for the Equity Shares to be allotted to qualified institutional buyers, pursuant to the Issue. We request you to take the above on record and the same be treated as compliance under the applicable provisions of the SEBI LODR Regulations.
|